specialty-header-image-2.png

BSG From the Boardroom

A curated selection of executive opportunities, industry highlights, and unique insights in executive search.

    BSG Team Ventures completes Bay Area Medical Devices CEO search for Novel Suturing Technology out of Stanford University

    closed-opportunity-search-BSG.jpg

    BSG  Team Ventures is pleased to announce the successful completion of CEO search for Zipline Medical.

    BSG recruited John Tighe, former CEO of PEAK Surgical, to join Zipline Founder & Chief Technology Officer Dr. Amir Belson.

    Prior to being recruited to ZipLine Medical, Mr. Tighe was a Director and President and CEO of PEAK Surgical, joining the company as its first employee in June 2006. In July 2011, he negotiated the acquisition of PEAK Surgical by Medtronic. Mr. Tighe was responsible for establishing clinical development and sales of PEAK’s novel radio frequency technology in a variety of surgical specialties, including General Surgery, ENT, Orthopedics, and Plastic Surgery. Prior to joining PEAK, he served as Senior Vice President and General Manager at Arthrocare Corp., where he managed the company’s three business units, comprised of Sports Medicine, ENT, and Spine. During his time at the company, Arthrocare was one of the fastest-growing publicly traded medical device companies. Mr. Tighe is a member of the Community Advisory Board of El Camino Hospital of Los Gatos (CA), and earned a bachelor’s degree in Civil Engineering at the University of Maryland.

    ZipLine Medical, headquartered in Campbell, Calif., is an emerging medical device company that has developed a platform technology — PRELOCTM (Pre-placement RE- aligning Low-tension Closure) — for noninvasive surgical skin closure via a simple, easy-to-learn and easy-to-use device. Because skin-closure is a common denominator of almost all surgeries, ZipLine’s PRELOC platform for the pre-placement, reapproximation and low-tension realignment of skin tissue has broad applicability across numerous medical specialties. There is an existing $4.2 billion worldwide market opportunity covering most surgical procedures involving skin incision. ZipLine’s initial target applications include: C-section, laparotomy, pacemaker/ICD implant, laparoscopic port, orthopedic, and excisional skin biopsy closure.

    For more information see, Zipline press release here

    -by Clark Waterfall on Oct 16, 2012 10:35:30 AM

    BROWSE BY CATEGORY

    7 High-Risk Search Strategies to Avoid Guide Download

    Subscribe to BSG

    Recent Posts

    get-in-touch-bsg.png

    Ready to work with BSG?

    We help the best in the business find the best for their business.